Literature DB >> 11388519

Rapacuronium and bronchospasm.

N G Goudsouzian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11388519     DOI： 10.1097/00000542-200105000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 3.  Pharmacokinetics and pharmacodynamics of rapacuronium bromide.

Authors:  William J Wight; Peter M C Wright
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  An overview of clinical research for anesthesiologists.

Authors:  Geetanjali Chilkoti; Chhavi S Sharma; Anjali Kochhar; Deepti Agrawal; A K Sethi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2010-10

Review 5.  Allosteric Modulation of Muscarinic Acetylcholine Receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

6.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.